Sponsor or institution
Clinical trials and research at Madrigal Pharmaceuticals, Inc.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Madrigal Pharmaceuticals, Inc. that are recruiting, at sites in 2 countries (most in United States (5), Canada (1)). By phase: Phase 2 (2), Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Rezdiffra with diabetes and pioglitazone or dapagliflozin in adults with MASH and F2-F3 fibrosis | Phase 4 | Chandler, Arizona and 15 other locations | Recruiting | Sep 29, 2026 |
| Resmetirom for MASH with HFpEF in adults | Phase 1 | Peoria, Arizona and 4 other locations | Recruiting | Sep 21, 2026 |
| Resmetirom in children and teens with MASH | Phase 2 | Indianapolis, Indiana | Recruiting | Aug 13, 2026 |
| Rezdiffra pregnancy and breastfeeding registry for women with NASH | — | West Conshohocken, Pennsylvania | Recruiting | Apr 21, 2026 |
| Resmetirom for post-liver transplant MASH with moderate to advanced fibrosis | Phase 2 | La Jolla, California and 16 other locations | Recruiting | Jan 13, 2026 |
All recruiting trials (5)
-
Rezdiffra with diabetes and pioglitazone or dapagliflozin in adults with MASH and F2-F3 fibrosis
This study tests whether Rezdiffra (resmetirom) can be safely used together with common diabetes medicines in adults with MASH and moderate to advanced liver fibrosis.
-
Resmetirom for MASH with HFpEF in adults
This study tests whether resmetirom can be given safely and show liver-related effects in adults with MASH and heart failure with preserved ejection fraction over 24 weeks.
-
Resmetirom in children and teens with MASH
This study tests how safe resmetirom is and how it acts in the body of kids aged 6 to 17 who have MASH with liver fibrosis.
-
Rezdiffra pregnancy and breastfeeding registry for women with NASH
This registry collects information about pregnancy and infant health for women with NASH who were exposed to Rezdiffra during pregnancy or while breastfeeding.
-
Resmetirom for post-liver transplant MASH with moderate to advanced fibrosis
This trial will test resmetirom versus placebo to see if it reduces liver fat and improves fibrosis in people who developed MASH after a liver transplant.
Quick answers
How many clinical trials run by Madrigal Pharmaceuticals, Inc. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.